Nobuyuki Hirai

Department Of Otolaryngology Head And Neck Surgery
Kanazawa, 9208640, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Recent Trends in Prevalence of HPV Infection in Nasopharyngeal Carcinoma in Japan.

Recent Trends in Prevalence of HPV Infection in Nasopharyngeal Carcinoma in Japan.

Journal: Microorganisms
Published: September 25, 2025

Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal Carcinoma.

Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal Carcinoma.

Journal: Cancer science
Published: September 20, 2025

HRAS Mutations in Head and Neck Carcinomas in Japanese Patients: Clinical Significance, Prognosis, and Therapeutic Potential.

HRAS Mutations in Head and Neck Carcinomas in Japanese Patients: Clinical Significance, Prognosis, and Therapeutic Potential.

Journal: International journal of molecular sciences
Published: February 21, 2025

Impact of Changes in Skeletal Muscle Mass Index on Prognosis During Alternating Chemoradiotherapy in Nasopharyngeal Carcinoma.

Impact of Changes in Skeletal Muscle Mass Index on Prognosis During Alternating Chemoradiotherapy in Nasopharyngeal Carcinoma.

Journal: Nutrition and cancer
Published: February 18, 2025

Head and Neck Cancer and Sarcopenia: An Integrative Clinical and Functional Review.

Head and Neck Cancer and Sarcopenia: An Integrative Clinical and Functional Review.

Journal: Cancers
Published: September 09, 2024

Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements.

Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements.

Journal: Thyroid research
Published: April 01, 2024

Phosphoribosyl pyrophosphate amidotransferase: Novel biomarker and therapeutic target for nasopharyngeal carcinoma.

Phosphoribosyl pyrophosphate amidotransferase: Novel biomarker and therapeutic target for nasopharyngeal carcinoma.

Journal: Cancer science
Published: February 29, 2024

Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.

Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.

Journal: International journal of cancer
Published: April 05, 2023

Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.

Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.

Journal: Cancers
Published: May 01, 2022

EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non-endemic region.

EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non-endemic region.

Journal: Cancer science
Published: October 08, 2021

Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma.

Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma.

Journal: Cancer science
Published: September 16, 2021

In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia.

In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia.

Journal: The Laryngoscope
Published: July 18, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026